Katada C, Muto M, Fujii S, et al. - Whether transoral surgery is a safe and efficacious treatment option for superficial head and neck cancer, was investigated in this nationwide multicenter study. From 27 hospitals in Japan, patients with superficial head and neck squamous cell carcinoma who were managed by transoral surgery were selected. There were 568 patients, among these, 662 lesions were primarily managed by 575 sessions of transoral surgery. In 12.7%, adverse events occurred. Occurrence of life‐threatening complications was documented in 0.5%, however, no treatment‐related deaths occurred. The 3‐year overall survival rate, relapse‐free survival rate, cause‐specific survival rate, and larynx‐preservation survival rate, during a median follow‐up of 46.1 months (range 1–113), were estimated to be 88.1%, 84.4%, 99.6%, and 87.5%, respectively. In the light of these findings, transoral surgery was concluded as an effective minimally invasive treatment for superficial head and neck cancer.